Down syndrome: Advances in molecular biology and the neurosciences

Research output: Contribution to journalArticle

Abstract

The entire DNA sequence for human chromosome 21 is now complete, and it is predicted to contain only about 225 genes, which is approximately three-fold fewer than the number initially predicted just 10 years ago. Despite this remarkable achievement, very little is known about the mechanism(s) whereby increased gene copy number (gene dosage) results in the characteristic phenotype of Down syndrome. Although many of the phenotypic traits show large individual variation, neuromotor dysfunction and cognitive and language impairment are observed in virtually all individuals. Currently, there are no efficacious biomedical treatments for these central nervous system-associated impairments. To develop novel therapeutic strategies, the effects of gene dosage imbalance need to be understood within the framework of those critical biological events that regulate brain organization and function.

Original languageEnglish (US)
Pages (from-to)40-59
Number of pages20
JournalJournal of Developmental and Behavioral Pediatrics
Volume22
Issue number1
StatePublished - 2001

Fingerprint

Gene Dosage
Neurosciences
Down Syndrome
Molecular Biology
Chromosomes, Human, Pair 21
Human Chromosomes
Therapeutic Uses
Language
Central Nervous System
Phenotype
Brain
Genes

Keywords

  • Alzheimer's disease
  • Brain development
  • Chromosome 21
  • Cognitive impairment
  • Down syndrome
  • Gene expression
  • Neurobiology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Behavioral Neuroscience
  • Psychology(all)
  • Developmental and Educational Psychology

Cite this

Down syndrome : Advances in molecular biology and the neurosciences. / Capone, George T.

In: Journal of Developmental and Behavioral Pediatrics, Vol. 22, No. 1, 2001, p. 40-59.

Research output: Contribution to journalArticle

@article{082be086cebc46328a6b363e5a96dc27,
title = "Down syndrome: Advances in molecular biology and the neurosciences",
abstract = "The entire DNA sequence for human chromosome 21 is now complete, and it is predicted to contain only about 225 genes, which is approximately three-fold fewer than the number initially predicted just 10 years ago. Despite this remarkable achievement, very little is known about the mechanism(s) whereby increased gene copy number (gene dosage) results in the characteristic phenotype of Down syndrome. Although many of the phenotypic traits show large individual variation, neuromotor dysfunction and cognitive and language impairment are observed in virtually all individuals. Currently, there are no efficacious biomedical treatments for these central nervous system-associated impairments. To develop novel therapeutic strategies, the effects of gene dosage imbalance need to be understood within the framework of those critical biological events that regulate brain organization and function.",
keywords = "Alzheimer's disease, Brain development, Chromosome 21, Cognitive impairment, Down syndrome, Gene expression, Neurobiology",
author = "Capone, {George T}",
year = "2001",
language = "English (US)",
volume = "22",
pages = "40--59",
journal = "Journal of Developmental and Behavioral Pediatrics",
issn = "0196-206X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Down syndrome

T2 - Advances in molecular biology and the neurosciences

AU - Capone, George T

PY - 2001

Y1 - 2001

N2 - The entire DNA sequence for human chromosome 21 is now complete, and it is predicted to contain only about 225 genes, which is approximately three-fold fewer than the number initially predicted just 10 years ago. Despite this remarkable achievement, very little is known about the mechanism(s) whereby increased gene copy number (gene dosage) results in the characteristic phenotype of Down syndrome. Although many of the phenotypic traits show large individual variation, neuromotor dysfunction and cognitive and language impairment are observed in virtually all individuals. Currently, there are no efficacious biomedical treatments for these central nervous system-associated impairments. To develop novel therapeutic strategies, the effects of gene dosage imbalance need to be understood within the framework of those critical biological events that regulate brain organization and function.

AB - The entire DNA sequence for human chromosome 21 is now complete, and it is predicted to contain only about 225 genes, which is approximately three-fold fewer than the number initially predicted just 10 years ago. Despite this remarkable achievement, very little is known about the mechanism(s) whereby increased gene copy number (gene dosage) results in the characteristic phenotype of Down syndrome. Although many of the phenotypic traits show large individual variation, neuromotor dysfunction and cognitive and language impairment are observed in virtually all individuals. Currently, there are no efficacious biomedical treatments for these central nervous system-associated impairments. To develop novel therapeutic strategies, the effects of gene dosage imbalance need to be understood within the framework of those critical biological events that regulate brain organization and function.

KW - Alzheimer's disease

KW - Brain development

KW - Chromosome 21

KW - Cognitive impairment

KW - Down syndrome

KW - Gene expression

KW - Neurobiology

UR - http://www.scopus.com/inward/record.url?scp=0034762806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034762806&partnerID=8YFLogxK

M3 - Article

C2 - 11265922

AN - SCOPUS:0034762806

VL - 22

SP - 40

EP - 59

JO - Journal of Developmental and Behavioral Pediatrics

JF - Journal of Developmental and Behavioral Pediatrics

SN - 0196-206X

IS - 1

ER -